Kestra Medical Technologies (KMTS) Consolidated Net Income (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Consolidated Net Income data on file, last reported at $77.3 million in Q2 2026.

• On a quarterly basis, Consolidated Net Income rose 267.07% year-over-year to $77.3 million in Q2 2026; TTM through Apr 2026 was -$15.5 million, a 85.81% increase from a year earlier, with the FY2026 full-year figure at -$15.5 million, up 85.81% from the prior year.
• Consolidated Net Income for Q2 2026 stood at $77.3 million, up from -$34.2 million in the prior quarter.
• Over the last five years, Consolidated Net Income for KMTS reached as high as $77.3 million in Q2 2026 and fell as low as -$46.3 million in Q2 2025.
• Historically, Consolidated Net Income has averaged -$16.6 million across 3 years, with a median of -$21.7 million in 2024.
• Across the five-year window, Consolidated Net Income tumbled 132.13% in 2025 and soared 267.07% in 2026, its largest moves.
• Year by year, Consolidated Net Income stood at -$20.6 million in 2024, then plunged by 58.99% to -$32.8 million in 2025, then surged by 335.82% to $77.3 million in 2026.
• Per Business Quant data, the three most recent Consolidated Net Income figures were $77.3 million in Q2 2026, -$34.2 million in Q1 2026, and -$32.8 million in Q4 2025.